Concepedia

Aromatase and COX-2 expression in human breast cancers

A. Brodie, Qing Lü, Brian J. Long, Amy M. Fulton, Tongzhen Chen, Nicol Macpherson, P.C DeJong, Marinus A. Blankenstein, J. W. R. Nortier, P. H. Th. J. Slee,

The Journal of Steroid Biochemistry and Molecular Biology · 2001 · 151 citations · 31 references

DOI

Concepts

References

31

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

Jean‐Marc Nabholtz, Aman U. Buzdar, Michaël Pollak et al. · Journal of Clinical Oncology · 2000 · 996 citations

, , +15

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P Dombernowsky, I E Smith, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1998 · 640 citations

, , +16

Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial

Manfred Kaufmann, Emilio Bajetta, Luc Dirix et al. · Journal of Clinical Oncology · 2000 · 525 citations

, , +14

Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue.

A.A.J. van Landeghem, J. Poortman, M.J.A. Nabuurs et al. · PubMed · 1985 · 450 citations

, , +14

Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.

Yan Zhao, Veena R. Agarwal, Carole R. Mendelson et al. · Endocrinology · 1996 · 424 citations

, , +16